(Q47738876)

5 February 2018

title

Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma (English)

1 reference

5 February 2018

author name string

Marko Lempinen

1

1 reference

5 February 2018

Ilaana Lyytinen

2

1 reference

5 February 2018

Arno Nordin

3

1 reference

5 February 2018

Taina Tervahartiala

4

1 reference

5 February 2018

Heikki Mäkisalo

5

1 reference

5 February 2018

Timo Sorsa

6

1 reference

5 February 2018

Helena Isoniemi

7

1 reference

5 February 2018

language of work or name

English

0 references

publication date

20 August 2013

1 reference

5 February 2018

published in

Annals of Medicine

1 reference

5 February 2018

volume

45

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

482-487

1 reference

5 February 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Hepatocellular carcinoma: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Proteases: multifunctional enzymes in life and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Introduction: MMPs, ADAMs/ADAMTSs research products to achieve big dream.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Novel functions of TIMPs in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

A new sensitive assay of human alpha-fetoprotein using time-resolved fluorescence and monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Protective roles of matrix metalloproteinases: from mouse models to human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Elevated levels of tissue inhibitor of metalloproteinases (TIMPS) in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Novel strategies for hepatocellular carcinoma based on MMPs science.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Enhanced migration of tissue inhibitor of metalloproteinase overexpressing hepatoma cells is attributed to gelatinases: relevance to intracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

TIMPs as multifacial proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Proteinases and their inhibitors in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

Matrix metalloproteinases and their inhibitors in tumour growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

New perspectives and strategy research biomarkers for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.823779

10.3109/07853890.2013.823779

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018